New Series: The Value of Personalized Medicine
For more than two years, the staff of and contributors to www.RealWorldHealthCare.org (RWHC) have been proud to share stories about proven healthcare solutions that lower costs, improve access to care, and lead to better patient outcomes.
Linda Barlow
Starting this Fall, RWHC will embark on a new mission. Each quarter, we will share ideas and insights from translational researchers working to bring new therapies to patients who need them. Our first series will focus on Personalized Medicine and Companion Diagnostics. Later series will cover topics such as:
- The Growing Role of Big Data in Oncology
- Determining the True Value of New Therapies
- What’s New in Orphan Drug Development
The new format will allow us to offer a deeper analysis of these emerging topics. Our approach will be to interview researchers who have published articles of interest in medical journals, about the real world implications of their findings. We look at it as “RWHC 2.0.”
We hope you enjoy hearing from the scientific leaders who are taking medicine in new directions to improve patient outcomes.
As always, we want to hear from you. Please take a brief moment to answer the survey question below and let us know what topics you’d like us to feature in future series.
[yop_poll id=”3″ tr_id=””” show_results=”-1″]
